Dr. Leibovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2001 - 2002
- Indiana University School of MedicineFellowship, Minimally Invasive Urologic Surgery, 2001 - 2001
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 1995 - 2001
- Albany Medical CollegeClass of 1995
- Cornell UniversityBA, Biochemistry, 1984 - 1989
Certifications & Licensure
- CA State Medical License 2001 - Present
- IA State Medical License 2021 - 2025
- MN State Medical License 1996 - 2025
- SD State Medical License Active through 2025
- AZ State Medical License 1997 - 1998
- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Distinguished Mayo Clinician Award Mayo Clinic, 2015
- Andrew C. Novick Award Kidney Cancer Association, 2014
- Join now to see all
Clinical Trials
- Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer Start of enrollment: 2003 Aug 01
- Exisulind Versus Placebo After Surgical Removal of the Prostate Start of enrollment: 2003 Feb 01
- Exisulind Prior to Radical Prostatectomy Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 134 citationsLymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical TemplatesPaul L. Crispen, Rodney H. Breau, Cristine Allmer, Christine M. Lohse, John C. Cheville
European Urology. 2011-01-01 - 243 citationsB7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survivalAmy E. Krambeck, R. Houston Thompson, Haidong Dong, Christine M. Lohse, Eugene S. Park
Proceedings of the National Academy of Sciences of the United States of America. 2006-07-05 - 687 citationsTumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich, Haidong Dong, Christine M. Lohse
Cancer Research. 2006-04-01
Journal Articles
- Radical Versus Partial Nephrectomy for cT1 Renal Cell CarcinomaBoris Gershman, Stephen A Boorjian, Bradley C Leibovich, European Urology
- Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base Eur Urol 2013;63:823-9Eisenberg MS, Leibovich BC, Kim SP. Re: Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al, Eur Urol, 7/2/2013
- Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristicsEisenberg MS, Leibovich BC, Kim SP, Cancer, 5/21/2013
- Join now to see all
Press Mentions
- Kidney CancerAugust 17th, 2024
- The Power of AI: Advanced Algorithm IDs Heart Issues Using Apple Watch DataNovember 23rd, 2022
- Study Shows Smartwatch EKG’s Ability to Accurately Detect Heart FailureNovember 15th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Society of Urologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: